U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07311395) titled 'Local Subcutaneous Gentamicin for Prevention of Surgical Site Infection After Elective Cesarean Section' on Dec. 15, 2025.
Brief Summary: The goal of this clinical trial is to evaluate whether local subcutaneous administration of gentamicin reduces the incidence of surgical site infection (SSI) following elective cesarean section. The study will also assess the safety of local gentamicin administration. The main questions this study aims to answer are:
* Does local subcutaneous administration of gentamicin reduce the rate of superficial and deep surgical site infections within 30 days after elective cesarean delivery?
* Are there d...